中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
12期
80-81,82
,共3页
陈咏君%陈咏玫%张立群%夏莉%吴丽霞%郭晶
陳詠君%陳詠玫%張立群%夏莉%吳麗霞%郭晶
진영군%진영매%장립군%하리%오려하%곽정
铜绿假单胞菌%耐药%分布
銅綠假單胞菌%耐藥%分佈
동록가단포균%내약%분포
Pseudomonas aeruginosa%Resistance%Distributed
目的:了解铜绿假单胞菌的感染情况及其耐药性,为临床合理应用抗生素提供科学依据。方法:收集本院临床分离铜绿假单胞菌,分析其科室分布、标本来源及耐药情况。结果:铜绿假单胞菌主要分布于干诊三病房(53.9%),主要以痰液分离最多(91.3%);其耐药率分别为:复方新诺明(100%)、头孢噻肟(83.94%)、庆大霉素(53.42%)、头孢他啶(51.83%)、氨曲南(50.55%)、头孢西林(50.27%)、环丙沙星(48.62%)、左氧氟沙星(44.95%)、妥布霉素(43.38%)、头孢吡肟(42.66%)、阿米卡星(26.30%)、哌拉西林/他唑巴坦(22.57%)、美罗培南(16.90%)、亚胺培南(14.39%)。结论:铜绿假单胞菌的耐药机制复杂,应加强医院耐药菌株的监测,指导临床合理使用抗生素,采取有效的防范措施最大限度减少铜绿假单胞菌感染。
目的:瞭解銅綠假單胞菌的感染情況及其耐藥性,為臨床閤理應用抗生素提供科學依據。方法:收集本院臨床分離銅綠假單胞菌,分析其科室分佈、標本來源及耐藥情況。結果:銅綠假單胞菌主要分佈于榦診三病房(53.9%),主要以痰液分離最多(91.3%);其耐藥率分彆為:複方新諾明(100%)、頭孢噻肟(83.94%)、慶大黴素(53.42%)、頭孢他啶(51.83%)、氨麯南(50.55%)、頭孢西林(50.27%)、環丙沙星(48.62%)、左氧氟沙星(44.95%)、妥佈黴素(43.38%)、頭孢吡肟(42.66%)、阿米卡星(26.30%)、哌拉西林/他唑巴坦(22.57%)、美囉培南(16.90%)、亞胺培南(14.39%)。結論:銅綠假單胞菌的耐藥機製複雜,應加彊醫院耐藥菌株的鑑測,指導臨床閤理使用抗生素,採取有效的防範措施最大限度減少銅綠假單胞菌感染。
목적:료해동록가단포균적감염정황급기내약성,위림상합리응용항생소제공과학의거。방법:수집본원림상분리동록가단포균,분석기과실분포、표본래원급내약정황。결과:동록가단포균주요분포우간진삼병방(53.9%),주요이담액분리최다(91.3%);기내약솔분별위:복방신낙명(100%)、두포새우(83.94%)、경대매소(53.42%)、두포타정(51.83%)、안곡남(50.55%)、두포서림(50.27%)、배병사성(48.62%)、좌양불사성(44.95%)、타포매소(43.38%)、두포필우(42.66%)、아미잡성(26.30%)、고랍서림/타서파탄(22.57%)、미라배남(16.90%)、아알배남(14.39%)。결론:동록가단포균적내약궤제복잡,응가강의원내약균주적감측,지도림상합리사용항생소,채취유효적방범조시최대한도감소동록가단포균감염。
Objective:To understand Pseudomonas aeruginosa infection and drug resistance for clinical rational use of antibiotics and provide scientific basis. Method:219 strains of clinical isolated pseudomonas aeruginosa were collected in our hospital,its distribution,specimen source department and drug resistance were analyzed. Result:Pseudomonas aeruginosa was mainly distributed in the three veteran cadres wards(53.9%),was mainly the separation of sputum specimens(91.3%);drug resistance rate:cotrimoxazole(100%),cefotaxime(83.94%),gentamicin(53.42%),ceftazidime(51.83%)aztreonam (50.55%),cephalosporins amoxicillin(50.27%),ciprofloxacin(48.62%),levofloxacin(44.95%),tobramycin(43.38%), cefepime(42.66%),amikacin(26.3%),piperacillin/tazobactam(22.57%),meropenem(16.9%),imipenem(14.39%). Conclusion:Drug resistance of Pseudomonas aeruginosa mechanism is complex,should strengthen the monitoring of hospital drug resistant strains,to guide clinical rational use of antibiotics,take effective measures to prevent minimize Pseudomonas aeruginosa infection.